IRD

NASDAQStock

Opus Genetics, Inc.

$5.02+0.18 (+3.72%)

52-Week Range

$0.71

$4.89

Key Stats

Market Cap

346.2M

P/E Ratio

—

Dividend Yield

—

Beta

0.59

Volume

1.1M

Avg Volume

1.1M

Performance

+42.77%

+127.23%

+253.28%

YTD

+128.30%

+417.70%

+328.32%

Price Chart

ETF Exposure

IRD is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VXF	Vanguard Extended Market ETF	0.00%	431,277	$996K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	93	$291	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	3,327	$10K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	16	$50	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,894,478	$4.4M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	9,964	$31K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	859	$3K	$1.29B	0.17%

About IRD ETF Exposure

Opus Genetics, Inc. (IRD) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 346.2M, IRD is a widely held institutional stock. The stock currently trades at $5.02. Investors can gain exposure to IRD through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IRD, sorted by portfolio weight.